Meningitis B vaccine (2026)

Concepts

• meningitis b vaccine
• the meningococcal group b vaccine
• meningococcal b (menb) disease
• vaccine
• meningitis
• jcvi advice
• risk adults
• gonorrhoea
• the national childhood immunisation programme
• jcvi

Location

Description

The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea. This notice provides an indication to the market of UKHSA's intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the meningococcal group B vaccine, in accordance with JCVI advice.

Award Detail

CPV Codes

• None found

Legal Justification

The following conditions are met in relation to the public contract under Schedule 5, Paragraph 5 (a, b) of the Procurement Act 2023- (a) due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **